Literature DB >> 20595413

The role of a prescription in anxiety medication use, abuse, and dependence.

Miriam C Fenton1, Katherine M Keyes, Silvia S Martins, Deborah S Hasin.   

Abstract

OBJECTIVE: Prescriptions for anxiety medications have increased substantially in recent years. Individuals with anxiety disorders are at risk of nonmedical use of these medications, but information about whether this risk is elevated among patients with a prescription for such medications is lacking. The authors compared risk of nonmedical use in individuals in a national sample with and without a prescription for anxiety medication and identified characteristics associated with nonmedical use.
METHOD: Data were drawn from face-to-face surveys of 34,653 adult participants in the National Epidemiologic Survey on Alcohol and Related Conditions. The risk of nonmedical use of prescription anxiety medication and associated drug use disorders was computed for individuals who had or had not ever received a prescription for anxiety medication; among those who had received a prescription, characteristics associated with nonmedical use were analyzed.
RESULTS: Prescription of anxiety medication was associated with lifetime and past-year nonmedical use (odds ratios, 1.6 and 1.9, respectively) and lifetime DSM-IV abuse or dependence (odds ratio, 2.6). Among respondents who received a prescription (N=4,294), nonmedical use was associated with male sex, younger age, white race, history of use of illicit drugs, history of other drug use disorders, and history of illegal behaviors.
CONCLUSIONS: These results indicate that prescription for anxiety medications is associated with nonmedical use of these medications, although the direction of causality cannot be determined in this study. Although anxiety medications have clinical utility, greater clinical attention should be given to the potential for their abuse among patients at particular risk.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595413      PMCID: PMC3756550          DOI: 10.1176/appi.ajp.2010.09081132

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  29 in total

1.  Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN.

Authors:  L B Cottler; B F Grant; J Blaine; V Mavreas; C Pull; D Hasin; W M Compton; M Rubio-Stipec; D Mager
Journal:  Drug Alcohol Depend       Date:  1997-09-25       Impact factor: 4.492

2.  Nosological comparisons of alcohol and drug diagnoses: a multisite, multi-instrument international study.

Authors:  D Hasin; B F Grant; L Cottler; J Blaine; L Towle; B Ustün; N Sartorius
Journal:  Drug Alcohol Depend       Date:  1997-09-25       Impact factor: 4.492

3.  The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample.

Authors:  D Hasin; K M Carpenter; S McCloud; M Smith; B F Grant
Journal:  Drug Alcohol Depend       Date:  1997-03-14       Impact factor: 4.492

Review 4.  Benzodiazepine self-administration in humans and laboratory animals--implications for problems of long-term use and abuse.

Authors:  R R Griffiths; E M Weerts
Journal:  Psychopharmacology (Berl)       Date:  1997-11       Impact factor: 4.530

5.  The reliability of the family history method for psychiatric diagnoses.

Authors:  M Zimmerman; W Coryell; B Pfohl; D Stangl
Journal:  Arch Gen Psychiatry       Date:  1988-04

6.  The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample.

Authors:  B F Grant; T C Harford; D A Dawson; P S Chou; R P Pickering
Journal:  Drug Alcohol Depend       Date:  1995-07       Impact factor: 4.492

7.  Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; W June Ruan; Roger P Pickering
Journal:  Arch Gen Psychiatry       Date:  2004-04

8.  The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample.

Authors:  Bridget F Grant; Deborah A Dawson; Frederick S Stinson; Patricia S Chou; Ward Kay; Roger Pickering
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

Review 9.  Anxiety and addiction: a clinical perspective on comorbidity.

Authors:  R L DuPont
Journal:  Bull Menninger Clin       Date:  1995

10.  An 8-year follow-up of 450 sons of alcoholic and control subjects.

Authors:  M A Schuckit; T L Smith
Journal:  Arch Gen Psychiatry       Date:  1996-03
View more
  19 in total

1.  Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences.

Authors:  Stefanie Mache; Patrick Eickenhorst; Karin Vitzthum; Burghard F Klapp; David A Groneberg
Journal:  Wien Med Wochenschr       Date:  2012-06-16

2.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

3.  Age-specific risk of substance use disorders associated with controlled medication use and misuse subtypes in the United States.

Authors:  Sean Esteban McCabe; Timothy E Wilens; Carol J Boyd; Kao-Ping Chua; Terri Voepel-Lewis; Ty S Schepis
Journal:  Addict Behav       Date:  2018-11-14       Impact factor: 3.913

4.  Medical and nonmedical use of prescription sedatives and anxiolytics: Adolescents' use and substance use disorder symptoms in adulthood.

Authors:  Sean Esteban McCabe; Philip Veliz; Carol J Boyd; John E Schulenberg
Journal:  Addict Behav       Date:  2016-08-15       Impact factor: 3.913

Review 5.  The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings.

Authors:  Deborah S Hasin; Bridget F Grant
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-26       Impact factor: 4.328

6.  The latent structure and predictors of non-medical prescription drug use and prescription drug use disorders: a national study.

Authors:  Carlos Blanco; Claudia Rafful; Melanie M Wall; Chelsea J Jin; Bradley Kerridge; Robert P Schwartz
Journal:  Drug Alcohol Depend       Date:  2013-08-17       Impact factor: 4.492

7.  Does misuse lead to a disorder? The misuse of prescription tranquilizer and sedative medications and subsequent substance use disorders in a U.S. longitudinal sample.

Authors:  C J Boyd; B West; S E McCabe
Journal:  Addict Behav       Date:  2017-11-28       Impact factor: 3.913

8.  Opioid Analgesic Use in Patients with Ankylosing Spondylitis: An Analysis of the Prospective Study of Outcomes in an Ankylosing Spondylitis Cohort.

Authors:  Jonathan D Dau; MinJae Lee; Michael M Ward; Lianne S Gensler; Matthew A Brown; Thomas J Learch; Laura A Diekman; Amirali Tahanan; Mohammad H Rahbar; Michael H Weisman; John D Reveille
Journal:  J Rheumatol       Date:  2017-12-01       Impact factor: 4.666

9.  Disruptive office behaviors in the medical setting: associations with other clinical phenomena.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2013-03

10.  Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study.

Authors:  Carlos Blanco; Miren Iza; Robert P Schwartz; Claudia Rafful; Shuai Wang; Mark Olfson
Journal:  Drug Alcohol Depend       Date:  2013-01-08       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.